Napredna pretraga

Pregled bibliografske jedinice broj: 864288

Combination of CSF protein biomarkers and BDNF, IL10, and IL6 genotypes in early diagnosis of Alzheimer's disease


Babić Leko, Mirjana; Nikolac Perković, Matea; Klepac, Nataša; Borovečki, Fran; Pivac, Nela; Šimić, Goran
Combination of CSF protein biomarkers and BDNF, IL10, and IL6 genotypes in early diagnosis of Alzheimer's disease // Neurologia Croatica / Šimić, Goran ; Mimica, Ninoslav (ur.).
Tučepi: Denona d.o.o., 2016. str. 95-95 (poster, domaća recenzija, sažetak, ostalo)


Naslov
Combination of CSF protein biomarkers and BDNF, IL10, and IL6 genotypes in early diagnosis of Alzheimer's disease

Autori
Babić Leko, Mirjana ; Nikolac Perković, Matea ; Klepac, Nataša ; Borovečki, Fran ; Pivac, Nela ; Šimić, Goran

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, ostalo

Izvornik
Neurologia Croatica / Šimić, Goran ; Mimica, Ninoslav - Tučepi : Denona d.o.o., 2016, 95-95

Skup
Croatian Congress on Alzheimer's Disease (CROCAD- 16)

Mjesto i datum
Tučepi, Hrvatska, 05-08.10.2016

Vrsta sudjelovanja
Poster

Vrsta recenzije
Domaća recenzija

Ključne riječi
Alzheimer’s disease ; mild cognitive impairment ; BDNF ; IL10 ; IL6

Sažetak
Cerebrospinal fluid (CSF) biomarkers are mostly used for early detection of Alzheimer’s disease (AD) in the group of patients with mild cognitive impairment (MCI). However, detection of AD in asymptomatic individuals (preclinical AD) is critical. In this study we tested whether the diagnostic potential of core CSF biomarkers (amyloid β42 (Aβ42), total tau (t- tau) and tau phosphorylated at epitope 181 (p- tau181)) could be improved by genetic biomarkers related to inflammatory pathways (IL1α, IL1β, IL10 and IL6) and survival of neurons (BDNF). We compared if levels of Aβ42, t-tau and p-tau181 differed between patients with different BDNF (rs6265), IL1α (rs1800587), IL1β (rs1143623), IL10 (rs1800896) and IL6 (rs1800795) genotypes. Levels of p-tau181 were significantly higher in the mixed group (AD, MCI and control subjects) with GA in comparison to GG BDNF genotype (t = -2.079, df = 221, p = 0.039). Levels of Aβ42 were significantly higher in the group of control subjects with TT in comparison to TC IL10 genotype (t = 2.500, df = 7, p = 0.041), while p-tau181 levels were significantly higher in the group of MCI patients with GC in comparison to CC IL6 genotype (t = -2.300, df = 34, p = 0.028). Thus, the potential of selected BDNF (rs6265), IL10 (rs1800896) and IL6 (rs1800795) polymorphisms in early diagnosis of AD should be further tested and validated on larger cohorts of patients. This work was supported by the Croatian Science Foundation grant. no. IP- 2014-09-9730.

Izvorni jezik
Engleski

Znanstvena područja
Temeljne medicinske znanosti



POVEZANOST RADA


Projekt / tema
IP-2014-09-9730

Ustanove
Institut "Ruđer Bošković", Zagreb,
Medicinski fakultet, Zagreb